Filing Details

Accession Number:
0001237899-14-000070
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-27 16:17:37
Reporting Period:
2014-10-23
Filing Date:
2014-10-27
Accepted Time:
2014-10-27 16:17:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226435 A Murray Goldberg 777 Old Saw Mill River Road
Tarrytown NY 10591
Svp Administration & Asst Secr No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-23 60,000 $30.63 123,102 No 4 M Direct
Common Stock Disposition 2014-10-23 4,689 $391.93 118,413 No 4 F Direct
Common Stock Disposition 2014-10-23 28,523 $391.93 89,890 No 4 F Direct
Common Stock Disposition 2014-10-24 200 $395.96 89,690 No 4 S Direct
Common Stock Disposition 2014-10-24 775 $396.80 88,915 No 4 S Direct
Common Stock Disposition 2014-10-24 1,700 $397.65 87,215 No 4 S Direct
Common Stock Disposition 2014-10-24 2,100 $398.58 85,115 No 4 S Direct
Common Stock Disposition 2014-10-24 3,200 $399.37 81,915 No 4 S Direct
Common Stock Disposition 2014-10-24 7,531 $400.51 74,384 No 4 S Direct
Common Stock Disposition 2014-10-24 5,293 $401.51 69,091 No 4 S Direct
Common Stock Disposition 2014-10-24 2,500 $402.54 66,591 No 4 S Direct
Common Stock Disposition 2014-10-24 2,454 $403.50 64,137 No 4 S Direct
Common Stock Disposition 2014-10-24 1,035 $404.18 63,102 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-10-23 60,000 $0.00 60,000 $30.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,736 2020-12-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,650 Indirect By 401(k) Plan
Common Stock 750 Indirect by Spouse
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 775 shares of Company stock on October 24, 2014 at prices ranging from $396.28 to $396.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
  3. Represents volume-weighted average price of sales of 1,700 shares of Company stock on October 24, 2014 at prices ranging from $397.14 to $397.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
  4. Represents volume-weighted average price of sales of 2,100 shares of Company stock on October 24, 2014 at prices ranging from $398.03 to $398.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
  5. Represents volume-weighted average price of sales of 3,200 shares of Company stock on October 24, 2014 at prices ranging from $399.02 to $399.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
  6. Represents volume-weighted average price of sales of 7,531 shares of Company stock on October 24, 2014 at prices ranging from $400.10 to $400.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
  7. Represents volume-weighted average price of sales of 5,293 shares of Company stock on October 24, 2014 at prices ranging from $401.00 to $401.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
  8. Represents volume-weighted average price of sales of 2,500 shares of Company stock on October 24, 2014 at prices ranging from $402.00 to $402.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
  9. Represents volume-weighted average price of sales of 2,454 shares of Company stock on October 24, 2014 at prices ranging from $403.00 to $403.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
  10. Represents volume-weighted average price of sales of 1,035 shares of Company stock on October 24, 2014 at prices ranging from $404.00 to $404.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 24, 2014 at each separate price.
  11. The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013.